Friday, June 21, 2013
Two new drugs for advanced melanoma!
Tafinlar and Mekinist are now approved for advanced malignant melanoma. Tafinlar is approved for patients with the BRAF V600E gene mutation. Mekinist is approved for patients with either the BRAF V600E or V600K gene mutations.
Subscribe to:
Posts (Atom)